Elite Pharmaceuticals ELTP
OTC ELTP
$0.37 +0.05 (+14.06%)
As of: Nov 16, 2026 · 12:26 PM EST

Elite Pharmaceuticals (ELTP) Total Current Liabilities (2009 - 2026)

Updated

Elite Pharmaceuticals (ELTP) posted Total Current Liabilities of $18.15 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), up 70.1% from $10.67 million a year earlier but down 40.4% from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Total Current Liabilities (2009 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Elite Pharmaceuticals' Total Current Liabilities came in at $17.39 million, up 46.9% from FY2025.

  • Annual Total Current Liabilities shows a five-year compound annual growth rate of 24.5% (FY2021 to FY2026).
  • In prior fiscal years, Elite Pharmaceuticals' Total Current Liabilities was $11.84 million in FY2025 (-9.3%), $13.05 million in FY2024 (+66.6%), $7.83 million in FY2023 (+17.0%) and $6.69 million in FY2022 (+15.2%).
  • Quarterly Total Current Liabilities has run from a low of $5.88 million in fiscal Q3 2022 to a high of $30.44 million in fiscal Q1 2027 over five years.
  • On a year-over-year basis, Total Current Liabilities has increased in each of the last three quarters, with growth averaging 27.1% over the last eight quarters.
  • The strongest year-over-year quarter for Total Current Liabilities in the past five years was fiscal Q3 2024, with growth of 187.9%; the weakest was fiscal Q2 2025, with a decline of 32.6%.
  • According to Business Quant data, Total Current Liabilities for the three prior fiscal quarters was $30.44 million (Q1 2027), $17.39 million (Q4 2026) and $13.19 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,291.18 Bn 1,264.79 Bn 20.46 Bn 47.00 Bn
2 Johnson & Johnson 686.56 Bn 606.42 Bn 17.30 Bn 55.46 Bn
3 AbbVie 525.29 Bn 493.30 Bn 13.12 Bn 43.10 Bn
4 Merck 362.24 Bn 325.18 Bn 13.19 Bn 28.80 Bn
5 Novartis Ag 313.66 Bn 286.90 Bn - -
6 Astrazeneca 286.68 Bn 260.20 Bn 13.26 Bn -31.27 Bn
7 Amgen 253.44 Bn 205.10 Bn 7.58 Bn 23.23 Bn
8 Gilead Sciences 210.62 Bn 185.73 Bn 6.73 Bn 12.00 Bn
9 Pfizer 165.41 Bn 112.77 Bn 12.56 Bn 31.73 Bn
10 Elite Pharmaceuticals 397.46 Mn 270.87 Mn 15.99 Mn 18.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 18.15 Mn
Jun 30, 2026 30.44 Mn
Mar 31, 2026 17.39 Mn
Dec 31, 2025 13.19 Mn
Sep 30, 2025 10.67 Mn
Jun 30, 2025 10.76 Mn
Mar 31, 2025 11.84 Mn
Dec 31, 2024 14.69 Mn
Sep 30, 2024 12.85 Mn
Jun 30, 2024 14.01 Mn
Mar 31, 2024 13.05 Mn
Dec 31, 2023 19.16 Mn
Sep 30, 2023 19.08 Mn
Jun 30, 2023 12.08 Mn
Mar 31, 2023 7.83 Mn
Dec 31, 2022 6.65 Mn
Sep 30, 2022 6.84 Mn
Jun 30, 2022 7.08 Mn
Mar 31, 2022 6.69 Mn
Dec 31, 2021 5.88 Mn
API Access

Elite Pharmaceuticals Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ELTP&period=max&api_key=YOUR_API_KEY